ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TAU Tau Capital Plc

0.00175
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tau Capital Plc LSE:TAU London Ordinary Share IM00B1VVFG94 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00175 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Tau Capital PLC Completion of Disposal (5183E)

18/10/2018 3:20pm

UK Regulatory


Tau Capital (LSE:TAU)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Tau Capital Charts.

TIDMTAU

RNS Number : 5183E

Tau Capital PLC

18 October 2018

18 October 2018

Tau Capital plc

("Tau" or the "Company")

Completion of Disposal

Further to the Company's announcement made on 4 October 2018, Tau announces that the disposal of the Company's indirect interest in Stopharm LLP has today completed.

The Company is now no longer classified as an investing company and will be classified as an AIM Rule 15 cash shell and as such will be required to make an acquisition or acquisitions which constitutes a reverse takeover under AIM Rule 14 on or before the date falling six months from today's date or be re-admitted to trading on AIM as an investing company under the AIM Rules (which requires the raising of at least GBP6 million) failing which, the Company's Ordinary Shares would then be suspended from trading on AIM pursuant to AIM Rule 40. Admission to trading on AIM would be cancelled six months from the date of suspension should the reason for the suspension not have been rectified.

Following the sale of the participation in Stopharm LLP, the Directors of the Company have resolved to set a timeline to receive and consider proposals for an acquisition or acquisitions which constitutes a reverse takeover under AIM Rule 14. If, after 30 November 2018, no acceptable proposals have been received, then the Board intends to distribute substantially all of the Company's remaining cash not required to meet operating costs and liabilities and seek a cancellation of the admission to trading of the Company's shares on AIM in accordance with AIM rule 41. This would be followed by the appointment of a liquidator of the Company.

Further announcements will be made in due course.

Further information, please contact:

 
 FIM Capital Limited 
  Philip Scales                         Tel: +44 (0) 1624 681250 
 
 Allenby Capital Limited (Nominated   Tel: +44 (0) 203 328 5656 
  Adviser and Joint Broker) 
  John Depasquale / Alex Brearley 
 
                                       Tel: +44 (0) 207 469 0933 
  Peterhouse Capital Limited (Joint 
  Broker) 
  Lucy Williams / Heena Karani 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DISGGGRGUUPRGCR

(END) Dow Jones Newswires

October 18, 2018 10:20 ET (14:20 GMT)

1 Year Tau Capital Chart

1 Year Tau Capital Chart

1 Month Tau Capital Chart

1 Month Tau Capital Chart

Your Recent History

Delayed Upgrade Clock